UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia : a CLCG-EORTC report

Leukemia, 2000-12, Vol.14 (12), p.2257-2266

2000

Volltextzugriff (PDF)

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)

British journal of haematology, 2001-12, Vol.115 (4), p.895-902

2001

Volltextzugriff (PDF)

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

Journal of clinical oncology, 1996-03, Vol.14 (3), p.911-918

1996

Volltextzugriff (PDF)

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

Leukemia, 2003-01, Vol.17 (1), p.60-67

2003

Volltextzugriff (PDF)

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2150-2159

1996

Volltextzugriff (PDF)

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia : final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

Leukemia, 2005-11, Vol.19 (11), p.1929-1933

2005

Volltextzugriff (PDF)

Modulation of multidrug-resistant multiple myeloma by cyclosporin

The Lancet (British edition), 1992-08, Vol.340 (8814), p.255-259

1992

Volltextzugriff (PDF)

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1268-1274

1989

Volltextzugriff (PDF)

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

Bone marrow transplantation (Basingstoke), 1997-08, Vol.20 (4), p.307-315

1997

Volltextzugriff (PDF)

Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)

Leukemia, 1995-11, Vol.9 (11), p.1805-1811

1995

Volltextzugriff (PDF)

Pentostatin in T-cell malignancies – a phase II trial of the EORTC

Annals of oncology, 1999-12, Vol.10 (12), p.1493-1498

1999

Volltextzugriff (PDF)

A Modular Questionnaire for the Assessment of Longterm Quality of Life in Leukaemia Patients: The MRC/EORTC QLQ-LEU

Quality of life research, 1996-02, Vol.5 (1), p.15-19

1996

Volltextzugriff (PDF)

FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress

Blood, 2003-09, Vol.102 (6), p.2198-2204

2003

Volltextzugriff (PDF)

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission : an analysis of the EORTC-GIMEMA AML 8A Trial

Bone marrow transplantation (Basingstoke), 1996-06, Vol.17 (6), p.993-1002

1996

Volltextzugriff (PDF)

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

The New England journal of medicine, 1995-01, Vol.332 (4), p.217-223

1995

Volltextzugriff (PDF)

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group

British journal of haematology, 1994-02, Vol.86 (2), p.284-290

1994

Volltextzugriff (PDF)

Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (8), p.658-662

1993

Volltextzugriff (PDF)

Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer

JNCI : Journal of the National Cancer Institute, 1990-09, Vol.82 (17), p.1416-1420

1990

Volltextzugriff (PDF)

Alternating v Repeated Postremission Treatment in Adult Acute Myelogenous Leukemia: A Randomized Phase III Study (AML6) of the EORTC Leukemia Cooperative Group

Blood, 1989-03, Vol.73 (4), p.896-906

1989

Volltextzugriff (PDF)

New trends in the treatment of adult acute myeloid leukaemia

European journal of cancer (1990), 1997-05, Vol.33, p.S7-S14

1997

Volltextzugriff (PDF)

The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA

British journal of haematology, 1998-09, Vol.102 (5), p.1344-1353

1998

Volltextzugriff (PDF)

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group

Journal of clinical oncology, 1997-05, Vol.15 (5), p.1824-1830

1997

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Humans
(88)
Life Sciences & Biomedicine
(86)
Female
(60)
Male
(60)
Middle Aged
(60)
Biological And Medical Sciences
(56)
Medical Sciences
(56)
Adult
(36)
Aged
(35)
Oncology
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Pharmacology. Drug Treatments
(31)
Antineoplastic Agents
(24)
Chemotherapy
(24)
Hematology
(24)
Adolescent
(23)
Risk Factors
(23)
Prognosis
(22)
Glomerular Filtration Rate
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia : a CLCG-EORTC report

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group

Modulation of multidrug-resistant multiple myeloma by cyclosporin

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)

Pentostatin in T-cell malignancies – a phase II trial of the EORTC

A Modular Questionnaire for the Assessment of Longterm Quality of Life in Leukaemia Patients: The MRC/EORTC QLQ-LEU

FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission : an analysis of the EORTC-GIMEMA AML 8A Trial

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group

Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group

Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer

A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia

Alternating v Repeated Postremission Treatment in Adult Acute Myelogenous Leukemia: A Randomized Phase III Study (AML6) of the EORTC Leukemia Cooperative Group

New trends in the treatment of adult acute myeloid leukaemia

The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group

Suchergebnisse filtern